No Advantages to Using ADM in Implant-Based Breast Reconstruction No Advantages to Using ADM in Implant-Based Breast Reconstruction
Contrary to previous studies, the use of acellular dermal matrix in breast reconstruction after a mastectomy did not have any advantage over conventional techniques.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 18, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA OKs Adjuvant Atezolizumab for Early-Stage Lung Cancer FDA OKs Adjuvant Atezolizumab for Early-Stage Lung Cancer
The drug is now also approved for adjuvant treatment following resection and platinum-based chemotherapy in early stage, non-small cell lung cancer with PD-L1 ≥ 1%.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 15, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

EU Panel Likes Two Cancer Drugs, Drops One EU Panel Likes Two Cancer Drugs, Drops One
Two new cancer drugs were recommended for approval, and one had its marketing authorization withdrawn at the October meeting of the European Medicines Agency's advisory panel.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 15, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Oncologist Recounts Difficulty of Mid-Career Move Oncologist Recounts Difficulty of Mid-Career Move
After 18 years at his first and only employer, oncologist Mikkael Sekeres, MD, decided it was time to move on. It wasn't easy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 15, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Younger, African American Women, and Men, Get Breast Cancer Too Younger, African American Women, and Men, Get Breast Cancer Too
An experienced nurse breaks down the facts about breast cancer during Breast Cancer Awareness Month and why it's more than a disease impacting middle-aged women.Medscape Blogs (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 15, 2021 Category: Cancer & Oncology Tags: Nursing Blog Source Type: news

Case Report: Lung Cancer Shrinks in Patient Using CBD Oil Case Report: Lung Cancer Shrinks in Patient Using CBD Oil
Dramatic tumor shrinkage is reported in a patient with lung cancer who declined standard treatment but ingested cannabidiol (CBD) oil long term.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 15, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Lupin Recalls Irbesartan & Hydrochlorothiazide/Irbesartan Tablets Lupin Recalls Irbesartan & Hydrochlorothiazide/Irbesartan Tablets
The voluntary nationwide recall was prompted by a possible impurity and affects all batches of the antihypertensive tablets.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 14, 2021 Category: Cancer & Oncology Tags: Cardiology News Alert Source Type: news

Henrietta Lacks Honored With WHO Director-General Award Henrietta Lacks Honored With WHO Director-General Award
The World Health Organization honored the late Henrietta Lacks with a WHO Director-General's award at a ceremony on Wednesday, with Lacks's 87-year-old son accepting on her behalf.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Case Report: Severe Hepatitis With Sotorasib After Immunotherapy Case Report: Severe Hepatitis With Sotorasib After Immunotherapy
A case report of life-threatening hepatitis in a lung cancer patient suggests caution when using second-line sotorasib in patients previously treated with checkpoint inhibitors.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

When Phase 3 Data Can't Guide Oncology Decision-Making When Phase 3 Data Can't Guide Oncology Decision-Making
Oncologist Jack West explores the limits of phase 3 data to provide clear treatment options for the many subgroups of patients.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Could Your Patient Benefit? New Trials in Lung Cancer Could Your Patient Benefit? New Trials in Lung Cancer
Trials of new drugs for lung cancer have begun enrollment in recent months, including several testing investigational new immunotherapies. Could one of your patients could benefit from being enrolled?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approves First-Line Pembrolizumab Plus Chemo for Cervical Cancer FDA Approves First-Line Pembrolizumab Plus Chemo for Cervical Cancer
The FDA has also approved pembrolizumab alone for patients with recurrent or metastatic cervical cancer.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

New Approval in Early Breast Cancer: First Advance in 20 Years New Approval in Early Breast Cancer: First Advance in 20 Years
The CDK4/6 inhibitor abemaciclib (Verzenio) has been approved for use in early breast cancer for certain patients who are at high risk for recurrence.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 13, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Why Black Women Are More Likely to Die of Endometrial Cancer Why Black Women Are More Likely to Die of Endometrial Cancer
In this Q&A, Kemi Doll, MD, MSCR, details her research journey to understand this major disparity and how to fix itMedscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 13, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Genes Related to Osteosarcoma Survival Identified Genes Related to Osteosarcoma Survival Identified
The newly discovered immune-related genes have been developed into a risk score model that predicts survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 12, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Community Mourns Nurse Knocked Over, Killed in Times Square Community Mourns Nurse Knocked Over, Killed in Times Square
Longtime oncology nurse honored at a mass in New York following days of public support after being knocked to the ground by a fleeing cellphone thief, who now faces murder charges.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 12, 2021 Category: Cancer & Oncology Tags: Nursing News Source Type: news

FDA Issued Postmarket CVD Safety Warning for 1 in 4 Cancer Drugs FDA Issued Postmarket CVD Safety Warning for 1 in 4 Cancer Drugs
Many of these alerts occurred almost 5 after the drug approval, but the overall risk for a major cardiac event remains small, lead author says.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 12, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Mobile Phone App Helps to Deliver Palliative Care Mobile Phone App Helps to Deliver Palliative Care
Dr David Kerr discusses a recent study of a mobile phone app designed to collect palliative outcomes data in sub-Saharan Africa.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 12, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

ASCO Esophageal Cancer Guidance Updated to Include Nivolumab ASCO Esophageal Cancer Guidance Updated to Include Nivolumab
The ASCO guidance has been updated to recommend adjuvant nivolumab in patients with residual disease following data from CheckMate 577 -- although caveats remain.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 11, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

How Breast Cancer Changed My Life...and Me How Breast Cancer Changed My Life...and Me
I was stunned. I was only 48 and healthy. How could this have happened? Where did this come from?WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 8, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Annual Cost of Cancer Care Reached $156 Billion Annual Cost of Cancer Care Reached $156 Billion
Breast, lung, and colorectal cancers were the most expensive to treatMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 8, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Only 10% of Patients Who Need Palliative Care Get It: WHO Report Only 10% of Patients Who Need Palliative Care Get It: WHO Report
The World Health Organization calls for"urgent and concerted action" to increase access to palliative care; only 39% of countries report that such care is generally available.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 8, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

The Return of Metastatic Prostate Cancer The Return of Metastatic Prostate Cancer
Henry Rosevear, MD, explores why we're seeing a rise in the incidence of metastatic prostate cancerMedscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 7, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

ESMO-MBCS Assesses Real Benefits of Cancer Treatments ESMO-MBCS Assesses Real Benefits of Cancer Treatments
A clinical-benefit scale, based on the analysis of relevant literature, can help clinicians and patients decide which cancer treatments to choose.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 7, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Women in Rural Areas Are Less Likely to Undergo CRC Screening Women in Rural Areas Are Less Likely to Undergo CRC Screening
But geography did not appear to have an impact on adherence to breast cancer screening guidelines.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 7, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Unprecedented' 3-Year Sustained Survival in SCLC With New Combo'Unprecedented' 3-Year Sustained Survival in SCLC With New Combo
The combination of durvalumab plus etoposide and cisplatin/carboplatin should now become the standard of care for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 7, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Massive Study Shows Impact of Colorectal Cancer Screening Massive Study Shows Impact of Colorectal Cancer Screening
David Kerr discusses a study of 3.1 million Europeans that illustrates the impact of national screening programs on colorectal cancer incidence, burden, and mortality.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 7, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Could Your Patients Benefit? New Trials in Colorectal Cancer Could Your Patients Benefit? New Trials in Colorectal Cancer
In recent months, a number of late-phase studies in colorectal cancer have started enrolling ― could one of your patients benefit?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 7, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Timing Is Crucial: Sooner Is Better for Rectal Cancer Surgery Timing Is Crucial: Sooner Is Better for Rectal Cancer Surgery
Survival outcomes are considerably better for patients with rectal cancer who have surgery within 8 weeks or less after not responding to neoadjuvant chemoradiation.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 7, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Half of US Children Under 6 Have Detectable Blood Lead Levels Half of US Children Under 6 Have Detectable Blood Lead Levels
Lead poisoning remains a significant threat to the health of young children in the United States, based on data from blood tests of more than 1 million children.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 6, 2021 Category: Cancer & Oncology Tags: Pediatrics News Source Type: news

Drugs for Symptom Control Add Cost Burden to Patients With Cancer Drugs for Symptom Control Add Cost Burden to Patients With Cancer
Commonly prescribed medications used to manage cancer-associated symptoms can inflict a significant financial burden.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 5, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Safe to Omit Bolus in 5-FU for Colorectal Cancer? Safe to Omit Bolus in 5-FU for Colorectal Cancer?
David Kerr discusses a recent study investigating the need for bolus 5-FU in the chemotherapy regimen for colorectal cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 5, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Stopping COVID-19 Misinformation: Why Call People Out? Stopping COVID-19 Misinformation: Why Call People Out?
Oncologist Don Dizon explores why physicians call out COVID-19 misinformation on TikTok and Twitter, and whether doing so actually changes peoples'minds.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 4, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Adjuvant IO Fails in BRCA+ Breast Cancer Patient; Now What? Adjuvant IO Fails in BRCA+ Breast Cancer Patient; Now What?
Dr Kathy Miller discusses potential treatment options for patients with triple-negative breast cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 1, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Increased Risk for Early-Onset CRC in Third-Degree Relatives Increased Risk for Early-Onset CRC in Third-Degree Relatives
The findings could influence future cancer screening recommendations, researchers suggest.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 30, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Please Keep Your Amateur Dietician Advice to Yourself Please Keep Your Amateur Dietician Advice to Yourself
Self-taught"experts" in human nutrition endanger cancer patients with their well-intentioned ideas.Medscape Blogs (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 30, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Blog Source Type: news

Cancer Among 9/11 Responders: Incidence and Risk Factors Cancer Among 9/11 Responders: Incidence and Risk Factors
First responders and rescue workers who arrived at the World Trade Center right after the attack were the most exposed to carcinogens and have the highest risk for certain cancers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Once-Daily Poziotinib Shows Efficacy in NSCLC HER2 Exon 20 Once-Daily Poziotinib Shows Efficacy in NSCLC HER2 Exon 20
The drug showed clinically meaningful efficacy for patients with treatment-naive nonsmall cell lung cancer HER2 exon 20 mutations.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Fired Oncologist Inspires Patient-Funded Billboards Fired Oncologist Inspires Patient-Funded Billboards
With more than 4000 supporters in Facebook groups, a fired oncologist has sparked the passion of his former patients, who want him back.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ACA Hardly Made a Dent in Catastrophic Cancer Costs ACA Hardly Made a Dent in Catastrophic Cancer Costs
Although the health reform legislation improved insurance churn, cancer patients are still vulnerable to financial toxicity, study finds.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

NCCN Guidelines Embrace PSMA-PET Imagining for Prostate Cancer NCCN Guidelines Embrace PSMA-PET Imagining for Prostate Cancer
Imaging with PSMA-PET excels at detecting small metastatic lesions in men with prostate cancer, but some specialists worry that it could lead to upstaging and overtreatment of men with lower-risk disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Use Live Donors for Liver Transplants for HCC Patients Use Live Donors for Liver Transplants for HCC Patients
For patients with hepatocelluar carcinoma (HCC), liver transplant from a live donor improves survival and frees up organs from deceased donors for other patients on the long waiting list.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 24, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

First Report of OS > 5 Years in Metastatic Breast Cancer First Report of OS > 5 Years in Metastatic Breast Cancer
The first report of a median overall survival (OS) exceeding 5 years in a phase 3 trial for advanced breast cancer comes from the MONALESSA-2 trial with ribociclib and letrozole.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Most Community-Based Oncologists Skip Biomarker Testing Most Community-Based Oncologists Skip Biomarker Testing
Fewer than half of community oncologists use biomarker testing to guide patient discussions about treatment, compared with 73% of academic clinicians.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Left-Breast Radiation Tied to Doubling of CAD Risk in Young Women Left-Breast Radiation Tied to Doubling of CAD Risk in Young Women
The study is novel in its focus on younger women and affirmed the excess risk for coronary artery disease (CAD) already well established in older breast cancer survivors.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2021 Category: Cancer & Oncology Tags: Cardiology News Source Type: news

Abiraterone Also Ups Survival in Nonmetastatic Prostate Cancer Abiraterone Also Ups Survival in Nonmetastatic Prostate Cancer
Latest results from the STAMPEDE trial show that adding abiraterone to androgen deprivation therapy improved both metastasis-free and overall survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Could Your Patient Benefit? New Clinical Trials in Breast Cancer Could Your Patient Benefit? New Clinical Trials in Breast Cancer
Several clinical trials in breast cancer have opened for enrollment in recent months. Your patients may be able to benefit by taking part.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Healthcare vs the Grim Reaper Healthcare vs the Grim Reaper
Labeling healthcare workers as warriors against death is setting them up for failure and burnout.Medscape Blogs (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Blog Source Type: news

FDA Approves Cabozantinib for Differentiated Thyroid Cancer FDA Approves Cabozantinib for Differentiated Thyroid Cancer
The FDA has approved cabozantinib for the treatment of advanced/metastatic differentiated thyroid cancer after disease progression.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Cancer Risk After Radioiodine for Hyperthyroidism Is'Small'Cancer Risk After Radioiodine for Hyperthyroidism Is'Small '
New meta-analysis shows that radioactive iodine treatment for hyperthyroidism doesn't significantly increase cancer risk or cancer mortality in the vast majority of cases.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 22, 2021 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news